DXM + Kratom (Mitragyna speciosa)

https://dxm-atlas.org/en/interactions/kratom/

Compare

Key points for this combination

A study found no change in DXM metabolism after a single low exposure to kratom [29]. This result applies to the tested conditions; the study did not assess sedation, larger amounts or repeated use.

General concepts in this text

Drug metabolism

Chemical transformation of a medicine in the body.

The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.

Sources: Drug metabolism

Sedation

A drug-induced state of calmness, relaxation or sleepiness.

Sources: Sedation

How well is this understood?

Mechanism confidence: medium

Confidence in the mechanism: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: medium

Confidence in direct human evidence involving DXM: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Measurements of drug concentration or metabolism.The study did not find the effect it tested for. Result in the interaction card

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: 3A — CYP3A metabolism (uncertain contribution)
ⓘ

CYP3A

A group of related CYP enzymes involved in the chemical transformation of medicines.

CYP3A is an enzyme group that includes CYP3A4 and CYP3A5.

Sources: CYP3A
  1. In a study of 12 healthy adults, a single low exposure to kratom tea did not change DXM AUC or Cmax when DXM was used as a CYP2D6 probe. Finding below: Finding [29] · 1

How can the effects add up?

Mechanism: OP — μ-opioid effects (uncertain contribution)
ⓘ

μ-opioid effects and associated respiratory hazards

Mechanism: SED — Sedation
ⓘ

Additive sedation, impaired consciousness or protective reflexes, and possible respiratory consequences

What remains unknown?

Under the studied conditions, no significant changes in these DXM pharmacokinetic measures were found. The result concerns a single low exposure to kratom tea. Higher or repeated exposures and concentrates are outside that scope. PHI 3–5 rests principally on extrapolation; the probability of sedation or aspiration remains uncertain [29].

Sources

Check the review’s wording

*A single low exposure did not alter DXM PK; sedation and other exposure conditions remain separate issues [29]

Combination row in the review: 3A — CYP3A metabolism? (uncertain contribution); OP — μ-opioid effects? (uncertain contribution); SED — Sedation

Evidence and sources

Research publication

[29] · Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom · 2023

Finding [29] · 1

What was found?

In a study of 12 healthy adults, a single low exposure to kratom tea did not change DXM AUC or Cmax when DXM was used as a CYP2D6 probe.

Finding [29] · 2

What limits this finding?

Under the studied conditions, no significant changes in these DXM pharmacokinetic measures were found. The result concerns a single low exposure to kratom tea. Higher or repeated exposures and concentrates are outside that scope. PHI 3–5 rests principally on extrapolation; the probability of sedation or aspiration remains uncertain [29].

Scientific review: Kratom

Related entries

Reference

Open the source and related combinations →